Showing results (271-280 of 599) with videos related to

Sort By:
Pageof 60
Diabetes Technology & Therapeutics|February 20, 2024
The Health Economics of Automated Insulin Delivery Systems and the Potential Use of Time in Range in Diabetes Modeling: A Narrative ReviewChantal Mathieu, Waqas Ahmed, Pieter Gillard, et al.
Critical Care Medicine|August 23, 2016
Vascular Endothelial Growth Factor Up-regulation in Human Amniotic Fluid Stem Cell Enhances Nephroprotection After Ischemia-Reperfusion Injury in the RatMarina Gabriela Monteiro Carvalho Mori da Cunha, Silvia Zia, Diego Vilibaldo Beckmann, et al.
Iscience|January 12, 2024
HAMSAB diet ameliorates dysfunctional signaling in pancreatic islets in autoimmune diabetesValerie Vandenbempt, Sema Elif Eski, Manoja K Brahma, et al.
Iscience|October 4, 2019
Longitudinal In Vivo Assessment of Host-Microbe Interactions in a Murine Model of Pulmonary AspergillosisShweta Saini, Jennifer Poelmans, Hannelie Korf, et al.
European Journal of Immunology|February 4, 2015
Macrophage dynamics are regulated by local macrophage proliferation and monocyte recruitment in injured pancreasNaomi Van Gassen, Eva Van Overmeire, Gunter Leuckx, et al.
Diabetes, Obesity & Metabolism|February 23, 2021
Long-term (52-week) efficacy and safety of dapagliflozin as an adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT-2 studyEiichi Araki, Chantal Mathieu, Toshihiko Shiraiwa, et al.
Diabetes/Metabolism Research and Reviews|November 10, 2011
Preservation of recall immunity in anti-CD3-treated recent onset type 1 diabetes patientsGonnie M Alkemade, Robert Hilbrands, Evy Vandemeulebroucke, et al.
Diabetes, Obesity & Metabolism|February 16, 2018
Safety and tolerability of dapagliflozin, saxagliptin and metformin in combination: Post-hoc analysis of concomitant add-on versus sequential add-on to metformin and of triple versus dual therapy with metforminStefano Del Prato, Julio Rosenstock, Ricardo Garcia-Sanchez, et al.
Diabetes Care|May 22, 2025
Early Detection of β-Cell Decline Using Home Dried-Blood-Spot C-Peptide Levels in New-Onset Type 1 DiabetesA Emile J Hendriks, M Loredana Marcovecchio, Mark L Evans, et al.
Medical Care|June 22, 2010
Monitoring modifiable cardiovascular risk in type 2 diabetes care in general practice: the use of an aggregated z-scoreGeert Goderis, Liesbeth Borgermans, Jan Heyrman, et al.
Pageof 60